HIV resistance testing is an important part of managing human immunodeficiency virus when treatment decisions require information about how the virus responds to antiretroviral medications. The test identifies genetic changes in HIV that may reduce the effectiveness of certain drugs. Healthcare professionals use these results alongside medical history, previous treatment experiences, viral load measurements, and other clinical information to develop an appropriate treatment plan. Understanding resistance testing can help individuals learn why some treatments work better than others and why ongoing monitoring matters.
HIV treatment has advanced significantly with the development of antiretroviral therapy (ART), which helps suppress viral replication and protect immune function. However, HIV can develop resistance to certain medications, potentially reducing treatment effectiveness. Resistance testing helps healthcare professionals identify relevant mutations and select medicines that are more likely to work. These tests are particularly useful when choosing an initial treatment regimen in certain circumstances or investigating a detectable viral load during treatment.
HIV resistance testing examines the virus for genetic changes associated with reduced susceptibility to antiretroviral drugs. Resistance may develop when the virus replicates while medication levels are insufficient to suppress it effectively. It can also be transmitted from one person to another, meaning resistance may exist before someone begins treatment.
Healthcare professionals select testing methods according to the patient's treatment history, viral load, and clinical circumstances.
Genotypic testing: Identifies genetic mutations associated with resistance to specific HIV medications. It is commonly used because it provides information about the virus's genetic profile.
Phenotypic testing: Measures how effectively HIV grows in the presence of different antiretroviral drugs. It may be useful in selected cases involving complex resistance patterns.
Baseline resistance testing: May be performed before starting treatment to identify transmitted resistance and help guide medication selection.
Resistance testing during treatment: May be recommended when viral suppression is not achieved or a previously suppressed viral load becomes persistently detectable.
Test results must be interpreted carefully. Resistance testing may not detect every resistant viral variant, particularly when the viral load is low or resistant variants are no longer prominent in the bloodstream. Previous resistance test results can therefore remain important even if a later test does not show the same mutations.
Resistance test results help healthcare professionals choose an antiretroviral regimen that is likely to suppress HIV effectively. The results are considered alongside treatment history, potential drug interactions, other health conditions, and individual treatment needs. A resistance result alone does not determine the entire treatment plan.
Important considerations include:
Selecting effective medications: Clinicians use identified mutations to understand which drugs may have reduced activity and which options may remain effective.
Reviewing previous treatment: Earlier regimens, medication changes, and documented resistance patterns can influence current decisions.
Investigating detectable viral loads: Healthcare professionals may assess adherence, drug interactions, absorption problems, and resistance when viral suppression is not maintained.
Monitoring treatment response: Follow-up viral load testing helps determine whether the selected regimen is achieving its intended effect.
Supporting ongoing care: Regular appointments and discussions about medication routines can help identify challenges before they affect long-term treatment outcomes.
People taking ART should not stop or change their medications without consulting their healthcare professional. Treatment interruptions can allow HIV to replicate and may increase the risk of resistance. If viral load remains detectable, clinicians can evaluate the possible causes and decide whether additional testing or a treatment adjustment is appropriate.
Resistance testing is one component of comprehensive HIV management. When interpreted together with viral load results, medical history, and other clinical findings, it helps support informed treatment decisions and sustained viral suppression.